We initially measured APE1 protein levels in biopsy tissue of NSCLC patients receiving platinum-based doublet chemotherapy by IHC, with the goal of correlating APE1 tissue expression with therapeutic response. This evidence concerns the gene APEX1 and non-small cell lung carcinoma.